Abnormalities Clinical Trials

51 recruitingLast updated: May 13, 2026

There are 51 actively recruiting abnormalities clinical trials across 29 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1. Top locations include Philadelphia, Pennsylvania, United States, New York, New York, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Abnormalities Trials at a Glance

51 actively recruiting trials for abnormalities are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Not Applicable with 14 trials, with the heaviest enrollment activity in Philadelphia, New York, and Boston. Lead sponsors running abnormalities studies include Chinese University of Hong Kong, Mayo Clinic, and Arizona State University.

Browse abnormalities trials by phase

Treatments under study

About Abnormalities Clinical Trials

Looking for clinical trials for Abnormalities? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Abnormalities trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Abnormalities clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 51 trials

Recruiting
Phase 2

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

HPV InfectionASC-USUterine Cervical Dysplasia+3 more
Amplexd Therapeutics, Inc.45 enrolled1 locationNCT07572396
Recruiting
Not Applicable

Effectiveness of the COPCA Program in Infants at Risk of Neurodevelopmental Disorders

Neurodevelopmental DisordersNeurodevelopmental Disorders and Developmental Abnormalities
University of Seville40 enrolled1 locationNCT07387627
Recruiting
Phase 3

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Interstitial Lung DiseasesFamilial Pulmonary FibrosisInterstitial Lung Abnormalities
Boehringer Ingelheim80 enrolled56 locationsNCT07201922
Recruiting

A Prospective Natural History Study of Lymphatic Anomalies

Lymphatic AbnormalitiesLymphatic Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1,200 enrolled2 locationsNCT05731141
Recruiting

Mayo AVC Registry and Biobank

CardiomyopathiesCardiovascular DiseasesSarcoidosis+14 more
Mayo Clinic1,000 enrolled2 locationsNCT03049254
Recruiting
Not Applicable

Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH

HerniaCongenital Diaphragmatic HerniaInternal Hernia+5 more
Johns Hopkins University80 enrolled1 locationNCT07166172
Recruiting

The Combined First Trimester Screening

Fetal Growth RestrictionPreterm LaborPreeclampsia (PE)+4 more
Institute of Health Information and Statistics of the Czech Republic2,000 enrolled3 locationsNCT07015203
Recruiting
Not Applicable

Visual Influences on Vestibular Adaptation

Vestibular HypofunctionBinocular Vision AbnormalitiesReduced Vision
Emory University100 enrolled2 locationsNCT07380256
Recruiting
Phase 4

GLP-1R Actions on Muscle and the Skeleton

ObesityOsteoporosisDrug Effect+2 more
Pennington Biomedical Research Center50 enrolled1 locationNCT07154719
Recruiting

MRI Study of Musculoskeletal Function

Patellofemoral Pain SyndromeAbnormalitiesImaging
National Institutes of Health Clinical Center (CC)750 enrolled1 locationNCT00051857
Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hodgkin LymphomaNon-Hodgkin LymphomaHematologic Malignancies+14 more
Center for International Blood and Marrow Transplant Research99,999 enrolled142 locationsNCT01351545
Recruiting

Mayo Clinic Upper Digestive Disease Survey

Esophageal CancerEsophagus CancerEsophageal Neoplasms+6 more
Mayo Clinic1,000 enrolled1 locationNCT02530983
Recruiting

Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders

Traumatic Brain Injury (TBI)Hypoxic-ischemic encephalopathy (HIE)Williams Syndrome+20 more
Healing Hope International100 enrolled1 locationNCT07493096
Recruiting

The effect of standardised pathway on the diagnosis and management of platelet-related bleeding disorders.

Inherited abnormalities in platelet number or platelet function.
Northern Sydney Local Health District350 enrolled1 locationACTRN12626000342314
Recruiting

Modeling Ocular Developmental Diseases From 3D Cultures of Optic Vesicle Organoids Derived From hiPSCs of Patients With Ocular Malformations

Eye Abnormalities
University Hospital, Toulouse20 enrolled2 locationsNCT06408701
Recruiting

Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh

Obesity, OverweightMAFLDMetabolic Abnormalities
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1,000 enrolled1 locationNCT07470749
Recruiting
Not Applicable

High Phenolic Olive Oil for Enhancing Metabolic Health: a Randomized-controlled Trial in Patients With cEntral Obesity (HOPE)

Overweight/ObesityAdultsMetabolic Abnormalities+1 more
University of Peloponnese80 enrolled1 locationNCT07445503
Recruiting

FACE.S-4-KIDS : A Deep Phenotyping Database of Craniofacial Anomalies During Development With 4 Pilot Projects

Craniofacial Abnormalities
Imagine Institute3,100 enrolled1 locationNCT07422454
Recruiting
Phase 1Phase 2

Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease

Malignant TumorHyperthyroidism, AutoimmuneCardiovascular Abnormalities
Peking Union Medical College Hospital600 enrolled1 locationNCT07400224
Recruiting
Not Applicable

Adequate Hydration and Health Outcomes

DehydrationCardiovascularDehydration (Physiology)+1 more
Arizona State University144 enrolled2 locationsNCT07179107